Betaserc - The mechanism of action of Betaserc is not known. Pharmacological testing in animals has shown that the blood circulation in the striae vascularis of the inner ear improves, probably by means of relaxation of the precapillary sphincters of the microcirculation of the inner ear. In pharmacological studies, Betaserc was found to have weak H1 receptor agonistic and considerable H3 antagonistic properties in the CNS and autonomic nervous system. Betaserc was also found to have a dose dependent inhibiting effect on spike generation of neurons in lateral and medial vestibular nuclei. The importance of these observations in the action against Menier’s syndrome or vestibular vertigo, however, remains unclear.
Indications: vestibular vertigo of different origin. conditions, which include vertigo and headache, noise in the ears, hardness of hearing, nausea and vomiting. disease/Meniere's syndrome.
Betaserc is used to treat vertigo (giddiness), tinnitus (ringing in the ears) and hearing loss in Meniere's disease. Betaserc helps to improve the blood circulation within the ear.
Meniere's syndrome as defined by the following trias of core symptoms: Vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus. Symptomatic treatment of vestibular vertigo.
Treatment of Meniere's syndrome which is usually characterized by dizziness, tinnitus, nausea and headache. This is often accompanied by loss of hearing. Symptomatic treatment of vestibular vertigo.
Symptomatic treatment of Meniere's syndrome eg, vertigo (with nausea/vomiting), hearing loss (difficulty in hearing), tinnitus.
Indications: Ménière`s disease
This medication is used to treat dizziness (vertigo) in those who have Meniere’s disease.